z-logo
Premium
Differential dendritic cell‐mediated activation and functions of invariant NKT ‐cell subsets in oral cancer
Author(s) -
Singh AK,
Gaur P,
Shukla NK,
Das SN
Publication year - 2015
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.12238
Subject(s) - natural killer t cell , flow cytometry , immunology , cd1d , immunotherapy , cytokine , cancer research , cell , glycolipid , t cell , biology , chemistry , microbiology and biotechnology , immune system , biochemistry
Objectives Invariant natural killer T (i NKT ) cells are unique subset of glycolipid‐reactive T lymphocytes with potent antitumour characteristics. This study was planned to understand Th‐like cytokine profiles of i NKT ‐cell subsets and modulation of their functions in response to glycolipid ligand and tumour cell lysate ( TL ). Subjects and Methods Cytokine profile of iNKT ‐cell subsets was evaluated from the peripheral blood of eight oral squamous cell carcinoma ( OSCC ) patients by flow cytometry and enzyme‐linked immunosorbent assay ( ELISA ), while antitumour activity of iNKT cells was measured by methyl tetrazolium salt assay. Results CD 4 + ( CD 4 + CD 8 − ) iNKT subset from OSCC patients showed significant ( P  < 0.01) expansion and higher IL‐4 production following activation with α ‐GalCer‐pulsed DC s, while CD 4 − CD 8 − double negative ( DN ) and CD 8 + ( CD 4 − CD 8 + ) i NKT subsets produced IFN ‐ γ predominantly. i NKT cells showed significantly ( P  = 0.02) increased secretion of IFN ‐ γ and enhanced cytotoxicity to KB and SCC ‐4 tumour cells in response to α ‐GalCer and TL ‐pulsed DC s. Conclusion It appears that mutual balance/ratio of i NKT subsets may be important for their effector functions. Selectively expanded DN and CD 8 + i NKT cells with α ‐GalCer and TL may be a better candidate vaccine for i NKT ‐cell‐based adoptive cancer immunotherapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom